BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32766146)

  • 1. Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia.
    Conneely SE; Cooper SL; Rau RE
    Front Oncol; 2020; 10():1129. PubMed ID: 32766146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment on the use of allopurinol to improve safety and efficacy of mercaptopurine in pediatric patients with Acute Lymphoblastic Leukemia and Lymphoma during maintenance therapy.
    Barone T; Dandekar S; McKeone D; Mulieri K
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1987. PubMed ID: 38351548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopurinol use during pediatric acute lymphoblastic leukemia maintenance therapy safely corrects skewed 6-mercaptopurine metabolism, improving inadequate myelosuppression and reducing gastrointestinal toxicity.
    Cohen G; Cooper S; Sison EA; Annesley C; Bhuiyan M; Brown P
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28360. PubMed ID: 32909665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of mercaptopurine-induced hypoglycemia using allopurinol to reduce methylated thiopurine metabolites.
    Miller MB; Brackett J; Schafer ES; Rau RE
    Pediatr Blood Cancer; 2019 Apr; 66(4):e27577. PubMed ID: 30548777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Retrospective Review of Mercaptopurine Metabolism Reveals High Rate of Patients With Suboptimal Metabolites Successfully Corrected With Allopurinol.
    Vasta LM; Zanetti RC; Parekh DS; Warwick AB; Lieuw K
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1003-e1009. PubMed ID: 32925411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.
    Giamanco NM; Cunningham BS; Klein LS; Parekh DS; Warwick AB; Lieuw K
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):147-51. PubMed ID: 26808368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acral Skin Rash Caused by Altered Mercaptopurine Metabolism in Maintenance Therapy for B-Cell Acute Lymphoblastic Leukemia.
    Newcome J; Geib KB; Thompson P; Gold S; Alexander TB
    J Pediatr Hematol Oncol; 2022 Oct; 44(7):398-401. PubMed ID: 35180762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolism.
    Brackett J; Schafer ES; Leung DH; Bernhardt MB
    Pediatr Blood Cancer; 2014 Jun; 61(6):1114-7. PubMed ID: 24376133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective evaluation of the impact of allopurinol in pediatric and adult IBD patients with preferential metabolism of 6-mercaptopurine to 6-methylmercaptopurine.
    Gerich ME; Quiros JA; Marcin JP; Tennyson L; Henthorn M; Prindiville TP
    J Crohns Colitis; 2010 Nov; 4(5):546-52. PubMed ID: 21122558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia.
    Zhang M; Bostrom B
    F1000Res; 2019; 8():176. PubMed ID: 30828444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tolerability of 6-mercaptopurine in children with acute lymphoblastic leukemia].
    Ma XL; Wang B; Guo HY; Zhang YH; Zhu GH; Duan YL; Yang J; Zhang DW; Jin L; Zhang R; Zhang L; Xie J; Wu MY
    Zhonghua Er Ke Za Zhi; 2010 Apr; 48(4):289-92. PubMed ID: 20654019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlations between 6-mercaptopurine treatment-related adverse reactions in children with acute lymphoblastic leukemia and polymorphisms of thiopurine methyltransferase gene].
    Xie C; Yue LJ; Ding H; Ren YF; Yang CL; Zheng MM
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 May; 16(5):499-503. PubMed ID: 24857000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease.
    Ansari A; Elliott T; Baburajan B; Mayhead P; O'Donohue J; Chocair P; Sanderson J; Duley J
    Aliment Pharmacol Ther; 2008 Sep; 28(6):734-41. PubMed ID: 19145729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine.
    Sparrow MP; Hande SA; Friedman S; Cao D; Hanauer SB
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):209-14. PubMed ID: 17296529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis.
    Zerra P; Bergsagel J; Keller FG; Lew G; Pauly M
    Pediatr Blood Cancer; 2016 Apr; 63(4):712-5. PubMed ID: 26878433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of allopurinol on 6-mercaptopurine metabolism in unselected patients with pediatric acute lymphoblastic leukemia: a prospective phase II study.
    Källström J; Niinimäki R; Fredlund J; Vogt H; Korhonen L; Castor A; Palle J; Harila A; Borssén M; Abrahamsson J; Ek T
    Haematologica; 2024 Feb; ():. PubMed ID: 38356449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ITPA Polymorphism on Adverse Drug Reactions of 6-Mercaptopurine in Pediatric Patients with Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis.
    Lee Y; Jang EJ; Yoon HY; Yee J; Gwak HS
    Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL).
    Stuckert AJ; Schafer ES; Bernhardt MB; Baxter P; Brackett J
    Leuk Lymphoma; 2020 May; 61(5):1246-1249. PubMed ID: 31842647
    [No Abstract]   [Full Text] [Related]  

  • 19. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.
    Sparrow MP; Hande SA; Friedman S; Lim WC; Reddy SI; Cao D; Hanauer SB
    Aliment Pharmacol Ther; 2005 Sep; 22(5):441-6. PubMed ID: 16128682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol.
    Zimm S; Collins JM; O'Neill D; Chabner BA; Poplack DG
    Clin Pharmacol Ther; 1983 Dec; 34(6):810-7. PubMed ID: 6580097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.